Clinical trial · Observational
Multi-omics Analyses on Etiology and Early Detection of Stomach Cancer Precursor Lesions
Multi-omics Approach for Identification of Etiopathogenesis and Early Detection Biomarkers of Stomach Cancer Precursor Lesions
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The overall aim is to utilize multi-omics approach to identify novel etiopathogenesis and early detection biomarkers for stomach cancer precursor lesions. To achieve this aim, first the investigators will use stored serum samples to perform metabolomics profiling among 12,599 twin subjects, among whom 1034 were deemed to have chronic atrophic gastritis based on measured pepsinogen I and II levels. Logistic regression will be used to search for metabolites related to the risk of chronic atrophic gastritis. Second, the investigators will further measure serum proteome by using two quantitatively precise proteomics assays, among the above-mentioned twin subjects. Identified protein biomarkers will be combined with metabolomics biomarkers to create a prediction model for chronic atrophic gastritis. The results will hopefully improve our understanding of the etiological factors and provide promising early detection biomarkers for stomach cancer precursor lesions.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Chronic Atrophic Gastritis | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Metabolomic profiling | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Participants with chronic atrophic gastritis
- description
- Corpus-dominant chronic atrophic gastritis was characterized by a PGI/PGII ratio of less than 3.
- interventionNames
- Other: Metabolomic profiling
- label
- Healthy participants
- description
- Healthy participants in the TwinGene cohort were included.
- interventionNames
- Other: Metabolomic profiling
Primary outcomes (1)
- measure
- Chronic atrophic gastritis
- timeFrame
- 1 Sep. 2020 to 31 Dec. 2021
- description
- Corpus-dominant chronic atrophic gastritis was characterized by a PGI/PGII ratio of less than 3.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 46 Years
- Maximum age
- 97 Years
Show eligibility criteria text
1. Inclusion Criteria: * participants from the Screening Across the Lifespan (SALT) study within Swedish Twin Registry (STR) who responded to a questionnaire on common diseases and provide a blood sample; * both twins in the pair had to be alive and living in Sweden; * had been enrolled in other STR DNA sampling projects; 2. Exclusion Criteria: * previously declined participation in future studies; * whose blood samples were unavailable or didn't pass initial lab-based QC; * whose samples were unable to link to the available environmental data.
References
Publications (0)
Data not yet available